These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
192 related articles for article (PubMed ID: 7743492)
1. Insulin-like growth factor I overexpression in human pancreatic cancer: evidence for autocrine and paracrine roles. Bergmann U; Funatomi H; Yokoyama M; Beger HG; Korc M Cancer Res; 1995 May; 55(10):2007-11. PubMed ID: 7743492 [TBL] [Abstract][Full Text] [Related]
2. Overexpression of the insulin-like growth factor-1 receptor and autocrine stimulation in human cervical cancer cells. Steller MA; Delgado CH; Bartels CJ; Woodworth CD; Zou Z Cancer Res; 1996 Apr; 56(8):1761-5. PubMed ID: 8620490 [TBL] [Abstract][Full Text] [Related]
3. Insulin-like growth factor family in malignant haemangiopericytomas: the expression and role of insulin-like growth factor I receptor. Pavelić K; Pavelić ZP; Cabrijan T; Karner I; Samarzija M; Stambrook PJ J Pathol; 1999 May; 188(1):69-75. PubMed ID: 10398143 [TBL] [Abstract][Full Text] [Related]
4. Fibroblast growth factor-5 stimulates mitogenic signaling and is overexpressed in human pancreatic cancer: evidence for autocrine and paracrine actions. Kornmann M; Ishiwata T; Beger HG; Korc M Oncogene; 1997 Sep; 15(12):1417-24. PubMed ID: 9333017 [TBL] [Abstract][Full Text] [Related]
5. Overexpressed IGF-I receptors reduce estrogen growth requirements, enhance survival, and promote E-cadherin-mediated cell-cell adhesion in human breast cancer cells. Guvakova MA; Surmacz E Exp Cell Res; 1997 Feb; 231(1):149-62. PubMed ID: 9056422 [TBL] [Abstract][Full Text] [Related]
6. Gastric cancer: the role of insulin-like growth factor 2 (IGF 2) and its receptors (IGF 1R and M6-P/IGF 2R). Pavelić K; Kolak T; Kapitanović S; Radosević S; Spaventi S; Kruslin B; Pavelić J J Pathol; 2003 Nov; 201(3):430-8. PubMed ID: 14595755 [TBL] [Abstract][Full Text] [Related]
7. Growth regulation of human glioblastoma T98G cells by insulin-like growth factor-1 and its receptor. Ambrose D; Resnicoff M; Coppola D; Sell C; Miura M; Jameson S; Baserga R; Rubin R J Cell Physiol; 1994 Apr; 159(1):92-100. PubMed ID: 8138595 [TBL] [Abstract][Full Text] [Related]
8. Aberrant expression and activation of insulin-like growth factor-1 receptor (IGF-1R) are mediated by an induction of IGF-1R promoter activity and stabilization of IGF-1R mRNA and contributes to growth factor independence and increased survival of the pancreatic cancer cell line MIA PaCa-2. Nair PN; De Armond DT; Adamo ML; Strodel WE; Freeman JW Oncogene; 2001 Dec; 20(57):8203-14. PubMed ID: 11781836 [TBL] [Abstract][Full Text] [Related]
9. Autocrine/paracrine involvement of insulin-like growth factor-I and its receptor in chronic lymphocytic leukaemia. Schillaci R; Galeano A; Becu-Villalobos D; Spinelli O; Sapia S; Bezares RF Br J Haematol; 2005 Jul; 130(1):58-66. PubMed ID: 15982345 [TBL] [Abstract][Full Text] [Related]
10. Inhibition of growth of prostatic cancer cell lines by peptide analogues of insulin-like growth factor 1. Pietrzkowski Z; Mulholland G; Gomella L; Jameson BA; Wernicke D; Baserga R Cancer Res; 1993 Mar; 53(5):1102-6. PubMed ID: 8439954 [TBL] [Abstract][Full Text] [Related]
11. Human osteosarcoma cell lines are dependent on insulin-like growth factor I for in vitro growth. Kappel CC; Velez-Yanguas MC; Hirschfeld S; Helman LJ Cancer Res; 1994 May; 54(10):2803-7. PubMed ID: 8168113 [TBL] [Abstract][Full Text] [Related]
12. Src stimulates insulin-like growth factor I (IGF-I)-dependent cell proliferation by increasing IGF-I receptor number in human pancreatic carcinoma cells. Flossmann-Kast BB; Jehle PM; Hoeflich A; Adler G; Lutz MP Cancer Res; 1998 Aug; 58(16):3551-4. PubMed ID: 9721859 [TBL] [Abstract][Full Text] [Related]
13. Inhibition of in vivo breast cancer growth by antisense oligodeoxynucleotides to type I insulin-like growth factor receptor mRNA involves inactivation of ErbBs, PI-3K/Akt and p42/p44 MAPK signaling pathways but not modulation of progesterone receptor activity. Salatino M; Schillaci R; Proietti CJ; Carnevale R; Frahm I; Molinolo AA; Iribarren A; Charreau EH; Elizalde PV Oncogene; 2004 Jul; 23(30):5161-74. PubMed ID: 15122317 [TBL] [Abstract][Full Text] [Related]
14. Enhanced expression of vascular endothelial growth factor in human pancreatic cancer correlates with local disease progression. Itakura J; Ishiwata T; Friess H; Fujii H; Matsumoto Y; Büchler MW; Korc M Clin Cancer Res; 1997 Aug; 3(8):1309-16. PubMed ID: 9815813 [TBL] [Abstract][Full Text] [Related]
15. Antitumor effects of an adenovirus expressing antisense insulin-like growth factor I receptor on human lung cancer cell lines. Lee CT; Wu S; Gabrilovich D; Chen H; Nadaf-Rahrov S; Ciernik IF; Carbone DP Cancer Res; 1996 Jul; 56(13):3038-41. PubMed ID: 8674059 [TBL] [Abstract][Full Text] [Related]
16. Increased expression of keratinocyte growth factor in human pancreatic cancer. Siddiqi I; Funatomi H; Kobrin MS; Friess H; Büchler MW; Korc M Biochem Biophys Res Commun; 1995 Oct; 215(1):309-15. PubMed ID: 7575607 [TBL] [Abstract][Full Text] [Related]
17. Growth-inhibitory effects of human anti-insulin-like growth factor-I receptor antibody (A12) in an orthotopic nude mouse model of anaplastic thyroid carcinoma. Wang Z; Chakravarty G; Kim S; Yazici YD; Younes MN; Jasser SA; Santillan AA; Bucana CD; El-Naggar AK; Myers JN Clin Cancer Res; 2006 Aug; 12(15):4755-65. PubMed ID: 16899627 [TBL] [Abstract][Full Text] [Related]
18. A fully human monoclonal antibody to the insulin-like growth factor I receptor blocks ligand-dependent signaling and inhibits human tumor growth in vivo. Burtrum D; Zhu Z; Lu D; Anderson DM; Prewett M; Pereira DS; Bassi R; Abdullah R; Hooper AT; Koo H; Jimenez X; Johnson D; Apblett R; Kussie P; Bohlen P; Witte L; Hicklin DJ; Ludwig DL Cancer Res; 2003 Dec; 63(24):8912-21. PubMed ID: 14695208 [TBL] [Abstract][Full Text] [Related]
19. Insulin-like growth factor-I and human lung fibroblast-derived insulin-like growth factor-I stimulate the proliferation of human lung carcinoma cells in vitro. Ankrapp DP; Bevan DR Cancer Res; 1993 Jul; 53(14):3399-404. PubMed ID: 8391925 [TBL] [Abstract][Full Text] [Related]
20. Targeting of urokinase plasminogen activator receptor in human pancreatic carcinoma cells inhibits c-Met- and insulin-like growth factor-I receptor-mediated migration and invasion and orthotopic tumor growth in mice. Bauer TW; Liu W; Fan F; Camp ER; Yang A; Somcio RJ; Bucana CD; Callahan J; Parry GC; Evans DB; Boyd DD; Mazar AP; Ellis LM Cancer Res; 2005 Sep; 65(17):7775-81. PubMed ID: 16140945 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]